Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-29

FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Torrent Pharmaceuticals Limited's supplemental application for risperidone, updating the labeling for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)